Yves Verboven

* 20+ years of strategic and operational experience in clinical and health economic evidence generation, leading to Class I indications, successful health technology assessment , supportive publication for reimbursement and business growth combined with
* 10 + years of heading MedTech Europe Trade association department of market access and economic policies with a drive to incorporating value in investment decisions and building out a shift from a price focused to a value based rewarding for medical technologies and innovative solution as well as striving for innovation accessibility pathways and medical & digital technologies specific adaptive approach on value assessment and now
* a way forward to unlock EU Regulation (starting with MDR/IVDR) for innovators leading to qualitative application to accelerated NB conformity assessment.
The innovation ecosystem would benefit from the advice - start/scale ups - SME as well as Multinationals as well as providers and government bodies